http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009124823-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfb2e45bf20f98254390fc3e49184747 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N57-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-1651 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-17 |
filingDate | 2009-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75a912a1ae45d92240a14bb1a7ef5862 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15c711f6e1b405875856d36b955fc661 |
publicationDate | 2009-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2009124823-A1 |
titleOfInvention | Process for preparing malathion for pharmaceutical use |
abstract | The present invention provides a process for preparing a highly pure form of malathion having a reduced level of toxic impurities. In addition, the malathion prepared by the process of this invention is storage stable. The level of toxic impurities in the malathion, e.g., isomalathion, O,O,S-trimethyl phosphorodithioate (MeOOSPS), O,O,S-trimethyl phosphorothioate (MeOOSPO), O,S,S-trimethyl phosphorodithioate (MeOSSPO), malaoxon, isomalathion, diethyl fumarate, methyl malathion, dimethyl malathion, O,O-methyl,ethyl-S-(1,2-dicarboethoxy)ethyl-phosphorodithioate are lower than that of any other commercial preparation of malathion that may be used for pharmaceutical purposes. |
priorityDate | 2005-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 196.